{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "16311913", "DateCompleted": {"Year": "2006", "Month": "04", "Day": "17"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0300-8177", "JournalIssue": {"Volume": "280", "Issue": "1-2", "PubDate": {"Year": "2005", "Month": "Dec"}}, "Title": "Molecular and cellular biochemistry", "ISOAbbreviation": "Mol Cell Biochem"}, "ArticleTitle": "A herbal medicine for the treatment of lung cancer.", "Pagination": {"StartPage": "125", "EndPage": "133", "MedlinePgn": "125-33"}, "Abstract": {"AbstractText": ["Lung cancer is the leading cause of cancer-related deaths throughout the world. Extracts of medicinal plants are believed to contain different chemopreventive or chemotherapeutic compounds. In this study, we determined the anti-cancer property of one of the traditional Indian medicine Rasagenthi Lehyam (RL) for the treatment of lung cancer. Two lung cancer cell lines (A-549 and H-460) and one normal bronchial epithelial (BEAS-2B) cell line were used to test the chemotherapeutic effect of RL. Out of five fractions of RL, chloroform fraction of RL (cRL) demonstrated a significant inhibition of cell proliferation and induction of apoptosis in A-549 and H-460 cells but not in normal BEAS-2B cells. The cRL fraction up-regulated the pro-apoptotic genes p53 and Bax and induced caspase-3 activation, and down-regulated the pro-survival gene Bcl-2 in both the lung cancer cell lines. Also, nuclear export of p53 was seen in cRL-treated lung cancer cells. In addition, cRL induced G2/M arrest of cell cycle and enhanced the radio-sensitivity of both the lung cancer cell lines. This study suggests that cRL may prove to be a potent anti-cancer agent that may be used for the treatment of lung cancer. However, further studies are required to bring cRL into the mainstream of medicine in the treatment of lung cancer."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Sciences, College of Health Sciences, University of Kentucky, Lexington, KY 40536-0200, USA."}], "Identifier": [], "LastName": "Ranga", "ForeName": "Rama S", "Initials": "RS"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Sowmyalakshmi", "ForeName": "Srinivasan", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Burikhanov", "ForeName": "Ravshan", "Initials": "R"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Akbarsha", "ForeName": "Mohammed A", "Initials": "MA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Chendil", "ForeName": "Damodaran", "Initials": "D"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Mol Cell Biochem", "NlmUniqueID": "0364456", "ISSNLinking": "0300-8177"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Proto-Oncogene Proteins c-bcl-2"}, {"RegistryNumber": "0", "NameOfSubstance": "Rasagenthi Lehyam"}, {"RegistryNumber": "0", "NameOfSubstance": "Tumor Suppressor Protein p53"}, {"RegistryNumber": "0", "NameOfSubstance": "bcl-2-Associated X Protein"}, {"RegistryNumber": "EC 3.4.22.-", "NameOfSubstance": "CASP3 protein, human"}, {"RegistryNumber": "EC 3.4.22.-", "NameOfSubstance": "Caspase 3"}, {"RegistryNumber": "EC 3.4.22.-", "NameOfSubstance": "Caspases"}], "MeshHeadingList": [{"QualifierName": ["drug effects"], "DescriptorName": "Active Transport, Cell Nucleus"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": [], "DescriptorName": "Caspase 3"}, {"QualifierName": ["metabolism"], "DescriptorName": "Caspases"}, {"QualifierName": ["drug effects", "radiation effects"], "DescriptorName": "Cell Cycle"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": ["drug effects", "genetics"], "DescriptorName": "Down-Regulation"}, {"QualifierName": ["drug effects"], "DescriptorName": "Enzyme Activation"}, {"QualifierName": [], "DescriptorName": "Flow Cytometry"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gene Expression Regulation, Neoplastic"}, {"QualifierName": [], "DescriptorName": "Herbal Medicine"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["ethnology"], "DescriptorName": "India"}, {"QualifierName": ["drug therapy", "pathology"], "DescriptorName": "Lung Neoplasms"}, {"QualifierName": [], "DescriptorName": "Medicine, Traditional"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["drug effects"], "DescriptorName": "Protein Transport"}, {"QualifierName": [], "DescriptorName": "Proto-Oncogene Proteins c-bcl-2"}, {"QualifierName": ["drug effects"], "DescriptorName": "Radiation Tolerance"}, {"QualifierName": ["metabolism"], "DescriptorName": "Tumor Suppressor Protein p53"}, {"QualifierName": ["metabolism"], "DescriptorName": "bcl-2-Associated X Protein"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Cell. 1993 Aug 27;74(4):597-608", "ArticleIdList": ["8358789"]}, {"Citation": "Lung Cancer. 1999 Nov;26(2):85-94", "ArticleIdList": ["10568679"]}, {"Citation": "Nat Med. 1996 May;2(5):574-7", "ArticleIdList": ["8616718"]}, {"Citation": "JAMA. 1998 Nov 11;280(18):1569-75", "ArticleIdList": ["9820257"]}, {"Citation": "Cancer Res. 2000 Feb 1;60(3):566-72", "ArticleIdList": ["10676638"]}, {"Citation": "Arch Pathol Lab Med. 1998 Apr;122(4):310-9", "ArticleIdList": ["9648897"]}, {"Citation": "Planta. 2005 Apr;220(6):910-8", "ArticleIdList": ["15517350"]}, {"Citation": "CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108", "ArticleIdList": ["15761078"]}, {"Citation": "Science. 1998 Aug 28;281(5381):1309-12", "ArticleIdList": ["9721092"]}, {"Citation": "Oncogene. 1994 Jun;9(6):1799-805", "ArticleIdList": ["8183579"]}, {"Citation": "Carcinogenesis. 2002 Nov;23(11):1869-76", "ArticleIdList": ["12419835"]}, {"Citation": "Cell. 1997 Feb 7;88(3):323-31", "ArticleIdList": ["9039259"]}, {"Citation": "Science. 1991 Jul 5;253(5015):49-53", "ArticleIdList": ["1905840"]}, {"Citation": "Nat Med. 2000 May;6(5):513-9", "ArticleIdList": ["10802706"]}, {"Citation": "Cell Death Differ. 2000 Dec;7(12):1146-54", "ArticleIdList": ["11175251"]}, {"Citation": "Cancer Res. 1999 Apr 1;59(7):1391-9", "ArticleIdList": ["10197600"]}, {"Citation": "Life Sci. 2001 Aug 17;69(13):1485-96", "ArticleIdList": ["11554610"]}, {"Citation": "Cell Growth Differ. 1994 Sep;5(9):983-93", "ArticleIdList": ["7819136"]}, {"Citation": "Int J Cancer. 2002 Nov 20;102(3):250-3", "ArticleIdList": ["12397644"]}, {"Citation": "Genes Dev. 1996 Jan 1;10(1):1-15", "ArticleIdList": ["8557188"]}, {"Citation": "Cancer. 2000 May 15;88(10):2398-424", "ArticleIdList": ["10820364"]}, {"Citation": "Cell. 1992 Aug 21;70(4):523-6", "ArticleIdList": ["1505019"]}, {"Citation": "Cancer Res. 2002 Jul 15;62(14):3920-4", "ArticleIdList": ["12124319"]}, {"Citation": "Genes Dev. 1996 May 1;10(9):1054-72", "ArticleIdList": ["8654922"]}, {"Citation": "Cancer Res. 1993 Jul 15;53(14):3321-6", "ArticleIdList": ["8324744"]}, {"Citation": "Nat Rev Cancer. 2002 Sep;2(9):647-56", "ArticleIdList": ["12209154"]}, {"Citation": "J Nutr. 2000 Feb;130(2S Suppl):467S-471S", "ArticleIdList": ["10721931"]}, {"Citation": "Cancer Chemother Pharmacol. 2004 Jul;54(1):7-15", "ArticleIdList": ["15042313"]}, {"Citation": "Oncogene. 2004 Feb 26;23(8):1599-607", "ArticleIdList": ["14985701"]}, {"Citation": "Prog Cell Cycle Res. 1996;2:165-73", "ArticleIdList": ["9552393"]}, {"Citation": "Histopathology. 2004 Jan;44(1):54-63", "ArticleIdList": ["14717670"]}, {"Citation": "Natl Vital Stat Rep. 2000 Jul 24;48(11):1-105", "ArticleIdList": ["10934859"]}, {"Citation": "J Clin Oncol. 2000 Jan;18(1):122-30", "ArticleIdList": ["10623702"]}, {"Citation": "Nature. 2000 Mar 2;404(6773):42-9", "ArticleIdList": ["10716435"]}, {"Citation": "Cell Death Differ. 2000 Feb;7(2):227-33", "ArticleIdList": ["10713737"]}, {"Citation": "J Nat Prod. 1997 Jan;60(1):52-60", "ArticleIdList": ["9014353"]}, {"Citation": "Cancer Chemother Pharmacol. 2002 Apr;49(4):261-6", "ArticleIdList": ["11914903"]}]}], "History": [{"Year": "2005", "Month": "3", "Day": "21"}, {"Year": "2005", "Month": "6", "Day": "2"}, {"Year": "2005", "Month": "11", "Day": "29", "Hour": "9", "Minute": "0"}, {"Year": "2006", "Month": "4", "Day": "18", "Hour": "9", "Minute": "0"}, {"Year": "2005", "Month": "11", "Day": "29", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["16311913", "10.1007/s11010-005-8518-3"]}}], "PubmedBookArticle": []}